Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17189418rdf:typepubmed:Citationlld:pubmed
pubmed-article:17189418lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C0335343lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C0147139lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C0596087lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C1704426lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C1709630lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C0920591lld:lifeskim
pubmed-article:17189418lifeskim:mentionsumls-concept:C1311871lld:lifeskim
pubmed-article:17189418pubmed:issue24lld:pubmed
pubmed-article:17189418pubmed:dateCreated2006-12-25lld:pubmed
pubmed-article:17189418pubmed:abstractTextThe angiogenic phenotype of malignant cancers has been established as a target for cancer therapy. ABT-526 and ABT-510, two peptide mimetics of thrombospondin-1 (TSP-1), block angiogenesis in vitro and in vivo and slow tumor growth in mice. To guide the clinical development of these drugs, translational studies in dogs with naturally occurring cancers were initiated.lld:pubmed
pubmed-article:17189418pubmed:languageenglld:pubmed
pubmed-article:17189418pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:citationSubsetIMlld:pubmed
pubmed-article:17189418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17189418pubmed:statusMEDLINElld:pubmed
pubmed-article:17189418pubmed:monthDeclld:pubmed
pubmed-article:17189418pubmed:issn1078-0432lld:pubmed
pubmed-article:17189418pubmed:authorpubmed-author:KhannaChandClld:pubmed
pubmed-article:17189418pubmed:authorpubmed-author:HenkinJackJlld:pubmed
pubmed-article:17189418pubmed:authorpubmed-author:HavivFortunaFlld:pubmed
pubmed-article:17189418pubmed:authorpubmed-author:MajestSandraSlld:pubmed
pubmed-article:17189418pubmed:authorpubmed-author:McKeeganEvely...lld:pubmed
pubmed-article:17189418pubmed:authorpubmed-author:RuskAnthonyAlld:pubmed
pubmed-article:17189418pubmed:issnTypePrintlld:pubmed
pubmed-article:17189418pubmed:day15lld:pubmed
pubmed-article:17189418pubmed:volume12lld:pubmed
pubmed-article:17189418pubmed:ownerNLMlld:pubmed
pubmed-article:17189418pubmed:authorsCompleteYlld:pubmed
pubmed-article:17189418pubmed:pagination7444-55lld:pubmed
pubmed-article:17189418pubmed:dateRevised2008-6-5lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:meshHeadingpubmed-meshheading:17189418...lld:pubmed
pubmed-article:17189418pubmed:year2006lld:pubmed
pubmed-article:17189418pubmed:articleTitlePreclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers.lld:pubmed
pubmed-article:17189418pubmed:affiliationAnimal Clinical Investigation, LLC, Columbia, Maryland, USA. trusk@animalci.comlld:pubmed
pubmed-article:17189418pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17189418pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17189418pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17189418lld:pubmed